TITLE 856 INDIANA BOARD OF PHARMACY
Emergency Rule
LSA Document #18-250(E)
DIGEST
Temporarily amends
856 IAC 2-2-2 to add synthetic drug compounds to Schedule I, II, and V. Statutory authority:
IC 25-26-13-4.1. Effective 30 days after filing with the Publisher.
(b) Unless specifically excepted or unless listed in another schedule, any material compound, mixture, or preparation, which contains any quantity of the following synthetic drugs, or which contains any of its salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation (for purposes of this subsection only, "isomer" includes the optical, position and geometric isomers):
(1) 4-fluoroisobutyryl fentanyl.
(2) methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate [5F-ADB; 5F-MDMB-PINACA].
(3) methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate [5F-AMB].
(4) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide [ADB-FUBINACA].
(5) N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide [5F-APINACA, 5F-AKB48].
(6) methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate [MDMB-CHMICA, MMB-CHMINACA].
(7) methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate [MDMB-FUBINACA].
(8) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1 H-indazole-3-carboxamide [MAB-CHMINACA and ADB-CHMINACA].
(9) Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylbutanoate [FUB-AMB, MMB-FUBINACA, AMB-FUBINACA].
(10) 3,4-dichloro-N-[(1dimethylamino)cyclohexylmethyl]benzamide) [AH7921].
(11) N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide, also known as N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide, (butyryl fentanyl).
(12) N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide, also known as N-[1-[2-hydroxy-2-(2-thienyl)ethyl]-4-piperidinyl]-N-phenylpropanamide, (beta-hydroxythiofentanyl).
(13) Furanyl fentanyl.
(b) Unless specifically excepted or unless listed in another schedule, any of the following opiates, including its isomers, esters, ethers, salts and salts of isomers, esters and ethers whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation:
Thiafentanil.
(b) Brivaracetam ((2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl] butanamide)).
Filed with Publisher: June 7, 2018, 1:57 p.m.
Posted: 06/13/2018 by Legislative Services Agency
DIN: 20180613-IR-856180250ERA
Composed: Apr 29,2024 2:00:45AM EDT
A
PDF version of this document.